Nadroparin | List of Frontiers open access articles

Original Research

Published on 31 Jan 2024

Is the current therapeutic dosage of nadroparin adequate for neonates and infants under 8 months with thromboembolic disease? a population pharmacokinetic study from a national children’s medical center

in Cardiovascular and Smooth Muscle Pharmacology

Yewei Chen
Jianger Lan
Lin Zhu
Min Dong
Yi Wang
Zhiping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1331673

2,211 views
1 citation

Case Report

Published on 10 Sep 2024

Case Report: A successful outcome of nadroparin calcium therapy for cerebral venous sinus thrombosis in a child with acute lymphoblastic leukemia

in Pediatric Hematology and Hematological Malignancies

Lichun Xie
Ye Xu
Guichi Zhou
Fen Chen
Changgang Li
Lian Ma
Feiqiu Wen

Frontiers in Pediatrics

doi 10.3389/fped.2024.1448445

2,450 views
1 citation

Original Research

Published on 24 Mar 2022

Sequential Therapy of Nadroparin and Rivaroxaban in the Initial Treatment of Patients With Acute Pulmonary Embolism

in Respiratory Pharmacology

Wei Xiong
Yunfeng Zhao
Song Liu
He Du
Yanmin Wang
Wenjie Li
Xuejun Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.810455

2,518 views
3 citations

Brief Research Report

Published on 24 Mar 2025

Low-molecular-weight heparins utilization in pregnant and postpartum women: a real-world analysis in China (2016–2021)

in Obstetric and Pediatric Pharmacology

Hao-Ran Liu
Kai Sun
Tao Zeng
Xian-Li Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1519051

3,598 views
1 citation

Original Research

Published on 10 Dec 2021

Safety and Efficacy of Low Molecular Weight Heparin for Thromboprophylaxis in the Elderly: A Network Meta-Analysis of Randomized Clinical Trials

in Cardiovascular and Smooth Muscle Pharmacology

Hui-qin Yang
Man-cang Liu
Wen-jun Yin
Ling-yun Zhou
Xiao-cong Zuo

Frontiers in Pharmacology

doi 10.3389/fphar.2021.783104

8,910 views
5 citations

Case Report

Published on 19 May 2023

Case report: reuse of tirofiban leads to very severe thrombocytopenia

in Cardiovascular Pharmacology and Drug Discovery

Yuqing Li
Jiuchun Qiu
Yi Gao
Guangping Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1130552

5,065 views
3 citations

Case Report

Published on 22 Jul 2024

Severe community-acquired pneumonia caused by Chlamydia abortus in China: a case report

in Pulmonary Medicine

Qiong-Fang Yang
Cai-Min Shu

Frontiers in Medicine

doi 10.3389/fmed.2024.1426577

3,289 views
4 citations

Articles

Is the current therapeutic dosage of nadroparin adequate for neonates and infants under 8 months with thromboembolic disease? a population pharmacokinetic study from a national children’s medical center

Case Report: A successful outcome of nadroparin calcium therapy for cerebral venous sinus thrombosis in a child with acute lymphoblastic leukemia

Sequential Therapy of Nadroparin and Rivaroxaban in the Initial Treatment of Patients With Acute Pulmonary Embolism

Low-molecular-weight heparins utilization in pregnant and postpartum women: a real-world analysis in China (2016–2021)

Safety and Efficacy of Low Molecular Weight Heparin for Thromboprophylaxis in the Elderly: A Network Meta-Analysis of Randomized Clinical Trials

Case report: reuse of tirofiban leads to very severe thrombocytopenia

Severe community-acquired pneumonia caused by Chlamydia abortus in China: a case report